SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- DNA Direct, a wholly owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS) and a leading provider of guidance and decision support for genomic medicine, announced today that Aspirus Wausau Hospital of Wausau, Wisconsin, Atlantic Health of Morristown, New Jersey, Crittenton Hospital Medical Center of Rochester, Michigan and Swedish Covenant Hospital of Chicago, Illinois, have joined the Genomic Medicine Network to provide personalized medicine services to their patients.
"We are very excited to have these innovative hospitals join the Genomic Medicine Network," said Ryan Phelan, Founder & President of DNA Direct. "Community hospitals are facing a challenging environment today and integrating personalized medicine into clinical care is a great way for hospitals to differentiate their services, educate medical staff and improve patient outcomes."
Launched in 2009, the Genomic Medicine Network (GMN) provides hospitals with both a patient and physician web-based personalized medicine portal. The patient portal provides educational content, decision support to help determine test appropriateness and access to genetic experts.
The physician portal assists physicians and medical staff as they make informed decisions that improve patient outcomes and includes web-based decision support, continuing education and training and access to genetic counselors that are available for consult.
With more than 2,000 diseases for which molecular diagnostic and genetic tests are available today, physicians need support determining which tests are clinically appropriate and clear guidance for diagnosis and treatment decisions. DNA Direct's resources help physicians identify risks and better
|SOURCE DNA Direct|
Copyright©2010 PR Newswire.
All rights reserved